Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Browsing Tag

Face

13 posts
NNestlé
7 confectionery trends set to dominate 2027
Read More

7 confectionery trends set to dominate 2027

  • 2026-11-10
From premium indulgence to multisensory textures, powerful forces are reshaping the future of confectionery. And the world’s biggest…
GGeneva
Dog burned in Geneva house fire is expected to recover, vet says
Read More

Dog burned in Geneva house fire is expected to recover, vet says

  • 2026-10-02
Dog burned in Geneva house fire that killed 15 other animals is expected to recover, vet says CASSELBERRY,…
NNestlé
The Manila Times
Read More

Nestle and Danone face fresh scrutiny over infant formula recalls

  • 2026-05-20
PARIS ― Nestle and Danone are facing fresh scrutiny over the handling of infant formula contamination after reports…
NNestlé
Nestlé's Leadership and Portfolio Face Critical April Tests
Read More

Nestlé’s Leadership and Portfolio Face Critical April Tests

  • 2026-04-12
Nestlé’s new CEO and Chairman debut at AGM amid strategic overhaul. Investors eye Q1 sales, a dividend vote,…
NNestlé
Nestlé's Strategic Maneuvers Face Market and Trade Headwinds
Read More

Nestlé’s Strategic Maneuvers Face Market and Trade Headwinds

  • 2026-04-11
Nestlé shares edge up but face pressure from potential US tariffs on Nespresso and a pivotal shareholder meeting.…
NNestlé
Nestlé's Leadership and Operations Face Twin Tests in April
Read More

Nestlé’s Leadership and Operations Face Twin Tests in April

  • 2026-04-09
Nestlé’s new chairman and CEO navigate a factory fire, pivotal shareholder meeting on dividends and board elections, and…
NNestlé
Nestlé's Leadership and Operations Face Twin Tests in April
Read More

Nestlé’s Leadership and Operations Face Twin Tests in April

  • 2026-04-09
Nestlé’s new chairman and CEO navigate a factory fire, pivotal shareholder meeting on dividends and board elections, and…
UUBS
UBS Shares Face Pressure Amid Trade Policy Shifts
Read More

UBS Shares Face Pressure Amid Trade Policy Shifts

  • 2026-04-06
UBS faces a critical month with Q1 earnings testing its post-merger strategy amid U.S. tariff headwinds and Swiss…
UUBS
UBS Shares Face Pressure Amid Trade Policy Shifts
Read More

UBS Shares Face Pressure Amid Trade Policy Shifts

  • 2026-04-05
UBS faces a critical month with Q1 earnings testing its post-merger strategy amid U.S. tariff headwinds and Swiss…
GGlencore
Glencore's South African Operations Face Critical Power Price Deadline
Read More

Glencore’s South African Operations Face Critical Power Price Deadline

  • 2026-03-21
Glencore faces a March 31 deadline to secure a discounted electricity deal with Eskom to save its ferrochrome…
UUBS
UBS Shareholders Face Pivotal Vote Amid Regulatory Crossroads
Read More

UBS Shareholders Face Pivotal Vote Amid Regulatory Crossroads

  • 2026-03-17
UBS AGM features a 22% dividend hike to $1.10/share, a $3B buyback plan, a board reshuffle, and faces…
RRoche
Roche's Weight-Loss Ambitions Face Reality Check
Read More

Roche’s Weight-Loss Ambitions Face Reality Check

  • 2026-03-09
Roche’s Petrelintide shows 9% net weight loss in Phase II, missing high expectations. Stock and partner Zealand Pharma…
Switzerland
www.europesays.com